THE FIRST ALL-RUSSIAN PHARMACOEPIDEMIOLOGICAL STUDY «EPIDEMIOLOGY OF DRUG USE IN PREGNANT WOMEN»: BASIC RESULTS


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

Objective. To study drug-prescribing tactics for pregnant women in different regions of Russia. Subjects and methods. A one-stage multicenter pharmacoepidemiological study was conducted. Questionnaire surveys were made among 1286 physicians of different specialties and 2324 pregnant women and puerperas. Results. Most physicians have been shown to be inadequately aware of the processes of organogenesis. It has been ascertained that the physicians prescribe a wide range of drugs to pregnant women and recommend drugs with unstudied safety to a fetus and those that are contraindicated in pregnancy. The pregnant women show a low adherence to the prescribed therapy and a high self-treatment rate. Subjects and methods. A one-stage multicenter pharmacoepidemiological study was conducted. Questionnaire surveys were made among 1286 physicians of different specialties and 2324 pregnant women and puerperas. Conclusion. It is necessary to update branch standards and to introduce pregnancy management protocols according to the data of evidence-based medicine, to adjust drug use instructions in accordance with updated clinical recommendations, to elaborate educational programs for the therapy of somatic diseases in pregnancy for physicians of different specialties, to set up an effectively operating pharmacovigilance system to monitor adverse reactions occurring with drug use in pregnancy, and to initiate the creation and maintenance of registers for using drugs in pregnant women.

Texto integral

Acesso é fechado

Sobre autores

O. TKACHEVA

Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

Email: tkacheva@rambler.ru

A. BEVZ

Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

E. USHKALOVA

Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

N. CHUKHAREVA

Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

Bibliografia

  1. Астахова А.В., Лепахин В.К. Лекарства. Неблагоприятные побочные реакции и контроль безопасности. — М.: Эксмо, 2008.
  2. Шефер К., Шпильтанн Х., Феттер К. Лекарственная терапия в период беременности и лактации. — М.: Логосфера, 2010.
  3. Anger G.J., Piquette-Miller M. Pharmacokinetic studies in pregnant women // Clin. Pharmacol. Ther. — 2008. — Vol. 83, № 1. — P. 184—187.
  4. Czeizel A.E. Epidemiological studies of congenital abnormalities in Hungary // Issues and reviews in teratology / Ed. H. Kalter-Dordrecht: Kluwer Academic Publishers, 2000. — Р. 85—124.
  5. Donati S., Baglio G., Spinelli A., Grandolfo M.E. Drug use in pregnancy among Italian women // Eur. J. Clin. Pharmacol. — 2000. — Vol. 56, № 4. — Р. 323—328.
  6. European Medicines Agency. Announcement of European Medicines Agency priorities for adverse drug reaction research. — London, 4 August 2009 Doc. Ref. EMEA/497624/2009. http://www.ema.europa.eu/pdfs/human/phv/49762409en.pdf.
  7. FDA, Health Organizations to Study Safety of Medications Taken During Pregnancy. For Immediate Release: Dec. 30, 2009. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm195934.htm.
  8. Lo W.Y., Friedman J.M. Teratogenicity of recently introduced medications in human pregnancy // Obstet. and Gynecol. — 2002. — Vol. 100. — Р. 465—473.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies